Does SECUKINUMAB Cause Mobility decreased? 3,342 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,342 reports of Mobility decreased have been filed in association with SECUKINUMAB (COSENTYX). This represents 2.2% of all adverse event reports for SECUKINUMAB.
3,342
Reports of Mobility decreased with SECUKINUMAB
2.2%
of all SECUKINUMAB reports
1,740
Deaths
2,071
Hospitalizations
How Dangerous Is Mobility decreased From SECUKINUMAB?
Of the 3,342 reports, 1,740 (52.1%) resulted in death, 2,071 (62.0%) required hospitalization, and 1,947 (58.3%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 3,342 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which SECUKINUMAB Alternatives Have Lower Mobility decreased Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG